Logo Logo

Publications by Ruckes, C.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 2.

Journal article

Elger, T.; Decker, T.; Fehm, T.; Fuxius, S.; Harbeck, N.; Juhasz-Böss, I.; Möbus, V.; Thomssen, C.; Seehase, M.; Schollenberger, L.; Ruckes, C.; Schmidt, M. (2017): VinoMetro: Phase II study of metronomic daily oral vinorelbine as first-line chemotherapy in advanced/metastatic hormone receptor positive (HR plus )/human epidermal growth factor receptor 2 negative (HER2-) breast cancer resistant to endocrine therapy. In: Annals of Oncology, Vol. 28

Krajnak, S.; Decker, T.; Fehm, T.; Fuxius, S.; Harbeck, N.; Juhasz-Böss, I.; Möbus, V.; Thomssen, C.; Seehase, M.; Schollenberger, L.; Ruckes, C.; Schmidt, M. (2017): VinoMetro: phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2-breast cancer resistant to endocrine therapy. In: Oncology Research and Treatment, Vol. 40: p. 88

This list was generated on Tue Nov 12 07:53:46 2019 CET.